+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma



Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma



Virchows Archiv 450(2): 135-141



The production of prostaglandins is regulated by cyclooxygenases (COXs), which also have a role in tumour development and progression in various human malignancies, including cholangiocarcinoma. Limited information is available of the correlation of COX-2 protein expression and prognosis in intrahepatic cholangiocarcinoma (ICC). The aim of the present study was to determine the clinical significance of COX-2 expression in ICC. In addition the correlation of COX-2 expression and apoptosis/proliferation was analysed. COX-2 expression was determined immunohistochemically in 62 resected ICCs. Proliferation was assessed using Ki67-immunohistochemistry, and apoptosis was measured with the TdT-mediated dUTP nick-end-labelling technique. COX-2 was identified as an independent prognostic factor (P = 0.028) in resected ICC by survival analysis. High levels of COX-2 expression were found to be associated both with reduced apoptosis and increased proliferation of tumour cells. This study demonstrates the independent prognostic value of the COX-2 expression in resected ICC, thus, offering a potential additional adjuvant therapeutic approach with COX-2 inhibitors.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012968579

Download citation: RISBibTeXText

PMID: 17165088

DOI: 10.1007/s00428-006-0355-6


Related references

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer 97(12): 2978-2987, 2003

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma. Oncotarget 7(32): 50963-50971, 2016

Is resection for solitary ≤5 cm intrahepatic cholangiocarcinoma an independent prognostic factor for survival?. Surgery 2018, 2018

CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Letters 235(1): 34-39, 2005

The associated expression of Maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinoma. Bmc Cancer 6: 255, 2006

Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery 16(4): 842-848, 2012

CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection. Anticancer Research 37(10): 5701-5705, 2017

Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma. Digestive and Liver Disease 37(4): 269-274, 2005

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma. Cancer Research and Treatment 45(1): 63-69, 2013

Expression of cyclooxygenase-2 in intrahepatic cholangiocarcinoma. Hepatology 30(4 PART 2): 277A, 1999

Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma. Hepato-Gastroenterology 56(91-92): 606-609, 2009

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut 48(1): 80-86, 2000

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut 48(1): 80-86, 2001

A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma. Anticancer Research 36(8): 4249-4258, 2017

Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. American Journal of Surgery 187(4): 538-542, 2004